Clinical Trial Results:
An open-label, multicenter, study to evaluate the safety, tolerability, pharmacodynamics, and pharmacokinetics of three dosing regimens of oral AT2220 in patients with Pompe disease
Summary
|
|
EudraCT number |
2008-002302-18 |
Trial protocol |
DE GB |
Global completion date |
14 Dec 2009
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v2(current) |
This version publication date |
22 Aug 2018
|
First version publication date |
11 Sep 2016
|
Other versions |
v1 |
Version creation reason |
|
Summary report(s) |
POM-CL-201 CSR Synopsis |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.